Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.2 USD | +17.65% | +20.99% | +73.40% |
Business Summary
Number of employees: 28
Managers
Managers | Title | Age | Since |
---|---|---|---|
John Celebi
CEO | Chief Executive Officer | 52 | 31/01/18 |
Erin Colgan
DFI | Director of Finance/CFO | 43 | 30/06/20 |
Chief Tech/Sci/R&D Officer | 51 | 31/08/19 | |
Alice Drumheller
CTO | Chief Tech/Sci/R&D Officer | - | 31/07/18 |
Michael Biega
IRC | Investor Relations Contact | - | 31/05/22 |
Stephanie Krebs
PRN | Corporate Officer/Principal | - | 10-31 |
General Counsel | - | 30/06/22 | |
Bao Le
LAW | General Counsel | - | 31/05/21 |
Corporate Officer/Principal | 44 | 31/05/22 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
William Ringo
CHM | Chairman | 78 | 07/03/22 |
John Celebi
CEO | Chief Executive Officer | 52 | 31/01/18 |
Bob Holmen
BRD | Director/Board Member | 60 | 31/12/16 |
Thomas Ricks
BRD | Director/Board Member | 70 | 31/12/14 |
Deneen Vojta
BRD | Director/Board Member | 59 | 28/01/20 |
James Peyer
BRD | Director/Board Member | 37 | 31/12/19 |
Kristian Humer
BRD | Director/Board Member | 49 | 29/07/21 |
Jessie English
BRD | Director/Board Member | 60 | 31/03/21 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 25,070,980 | 16,384,834 ( 65.35 %) | 0 | 65.35 % |
Company contact information
Sensei Biotherapeutics, Inc.
1405 Research Boulevard` Suite 125
20850, Rockville
+240 243 8000
http://senseibio.comSector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+73.40% | 25.57M | |
-2.67% | 102B | |
+2.35% | 96.09B | |
+2.13% | 22.28B | |
-17.22% | 21.4B | |
-8.79% | 18.14B | |
-39.98% | 17.02B | |
-13.83% | 16.09B | |
+5.67% | 13.83B | |
+32.24% | 11.97B |
- Stock Market
- Equities
- SNSE Stock
- Company Sensei Biotherapeutics, Inc.